Atlas FDA

CryoValve Heart-valve, allograft

FDA device recall Z-0723-03 · posted 2003-04-15 · Terminated

Recall details

Recalling firm
Cryolife Inc
Reason for recall
The recipient of one of the kidneys from the donor has developed renal cell carcinoma.
Action taken
Implanting physicians were notified by letter on 3/19/2003. Since CryoLife has been notified that the allografts have been implanted, the notification is intended to provide the physician with a basis to determine if any additional patient surveillance or intervention is necessary. They were advised to complete an enclosed, stamped, self-addressed postcard to affirm receipt of the notification.
Root cause
Other
Status
Terminated
Product code
LMO
Quantity affected
There are two individual heart valve allografts.
Distribution
Allografts were distributed to 2 physicians in NY and MS. Allografts were implanted.
Date initiated
2003-03-19
Date posted
2003-04-15
Date terminated
2003-05-05
Location
Kennesaw, GA

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.